• Martti Ala-Opas (Helsinki University Central Hospital, Finland)
• Ramon Alemany (Institut Catala d'Oncologica, Spain)
• Ronald D. Alvarez (University of Alabama at Birmingham, USA)
• Andy Baker (University of Glasgow, Scotland)
• John Bell (Ottawa Health Research Institute, Canada)
• Dung-Tsa Chen (University of South Florida, USA)
• David T. Curiel (University of Alabama at Birmingham, USA)
• Renee A. Desmond (University of Alabama at Birmingham, USA)
• Aris Eliopoulos (University of Crete, Greece)
• Reidar Grenman (University of Turku, Finland)
• Krister Höckerstedt (Helsinki University Central Hospital,Finland)
• Richard Iggo (University of St. Andrews, Scotland)
• Helena Isoniemi (Helsinki University Central Hospital, Finland)
• Kalevi Kairemo (Helsinki University Central Hospital, Finland)
• David Kirn (Jennerex, USA)
• Tuula Kiviluoto (Helsinki University Central Hospital, Finland)
• Petri Lehenkari (University of Oulu, Finland)
• Arto Leminen (Helsinki University Central Hospital, Finland)
• Andre Lieber (University of Washington, USA)
• Moninka Lusky (Transgene, France)
• Dirk Nettelbeck (Deutsches Krebsforschungszentrum, Germany)
• Ari Ristimäki (Helsinki University Central Hospital, Finland)
• Daniel Rein (University of Düsseldorf, Germany)
• Jarmo Salo (Helsinki University Central Hospital, Finland)
• Ulf-Håkan Stenman (Helsinki University Central Hospital, Finland)
• Mikko Tenhunen (Helsinki University Central Hospital, Finland)
• Thomas Tötterman (University of Uppsala, Sweden)

• Molecular Cancer Biology Program
• University of Helsinki
• Biomedicum Helsinki
• Hospital District of Helsinki and Uusimaa (HUS)
• National Library of Health Sciences (Terkko)
•  
• American Society of Gene Therapy (ASGT)
• European Society of Gene and Cell Therapy (ESGCT)
• Finnish Society of Gene Therapy (FSGT)
•  
• Web focus on oncolytic viruses:
•  
• Primer 3
• Tura apurahalista
•